These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 27632674)

  • 21. Nutrition Support for Persistent Inflammation, Immunosuppression, and Catabolism Syndrome.
    Moore FA; Phillips SM; McClain CJ; Patel JJ; Martindale RG
    Nutr Clin Pract; 2017 Apr; 32(1_suppl):121S-127S. PubMed ID: 28166447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preliminary discussion of therapeutic strategies in persistent inflammation immunosuppression catabolism syndrome].
    Su H; Guo Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Dec; 20(12):1444-1447. PubMed ID: 29280129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocyte Immunosuppression and Dysfunction Contributing to Persistent Inflammation, Immunosuppression, and Catabolism Syndrome (PICS).
    Bergmann CB; Beckmann N; Salyer CE; Crisologo PA; Nomellini V; Caldwell CC
    Shock; 2021 Jun; 55(6):723-741. PubMed ID: 33021569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunopathology of chronic critical illness in sepsis survivors: Role of abnormal myelopoiesis.
    Rincon JC; Efron PA; Moldawer LL
    J Leukoc Biol; 2022 Dec; 112(6):1525-1534. PubMed ID: 36193662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic Critical Illness: Current Aspects of the Problem (Review).
    Parfenov AL; Razzhivin VP; Petrova MV
    Sovrem Tekhnologii Med; 2022; 14(3):70-81. PubMed ID: 37064807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent inflammation, immunosuppression, and catabolism syndrome after severe blunt trauma.
    Vanzant EL; Lopez CM; Ozrazgat-Baslanti T; Ungaro R; Davis R; Cuenca AG; Gentile LF; Nacionales DC; Cuenca AL; Bihorac A; Leeuwenburgh C; Lanz J; Baker HV; McKinley B; Moldawer LL; Moore FA; Efron PA
    J Trauma Acute Care Surg; 2014 Jan; 76(1):21-9; discussion 29-30. PubMed ID: 24368353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity and sepsis.
    Vachharajani V; Vital S
    J Intensive Care Med; 2006; 21(5):287-95. PubMed ID: 16946444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HDL and persistent inflammation immunosuppression and catabolism syndrome.
    Barker G; Winer JR; Guirgis FW; Reddy S
    Curr Opin Lipidol; 2021 Oct; 32(5):315-322. PubMed ID: 34374677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysregulated Immunity and Immunotherapy after Sepsis.
    Darden DB; Kelly LS; Fenner BP; Moldawer LL; Mohr AM; Efron PA
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33920518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent inflammation-immunosuppression catabolism syndrome, a common manifestation of patients with enterocutaneous fistula in intensive care unit.
    Hu D; Ren J; Wang G; Gu G; Chen J; Zhou B; Liu S; Wu X; Li J
    J Trauma Acute Care Surg; 2014 Mar; 76(3):725-9. PubMed ID: 24553541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiological changes in the critically ill patient with sepsis.
    Hosein S; Udy AA; Lipman J
    Curr Pharm Biotechnol; 2011 Dec; 12(12):1991-5. PubMed ID: 21554219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sepsis: pathophysiology and clinical management.
    Gotts JE; Matthay MA
    BMJ; 2016 May; 353():i1585. PubMed ID: 27217054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent Inflammation, Immunosuppression, and Catabolism: Evolution of Multiple Organ Dysfunction.
    Rosenthal MD; Moore FA
    Surg Infect (Larchmt); 2016 Apr; 17(2):167-72. PubMed ID: 26689501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid Mediators in Critically Ill Patients: A Step Towards Precision Medicine.
    Cioccari L; Luethi N; Masoodi M
    Front Immunol; 2020; 11():599853. PubMed ID: 33324417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric Persistent Inflammation, Immunosuppression, and Catabolism Syndrome Prevalence in Sepsis-Related Mortalities: A 23-Year Institutional History.
    Patterson SG; Lamb CK; Gong W; Resser J; Lindsell CJ; Van Driest SL; Stark RJ
    Chest; 2023 Nov; 164(5):1204-1215. PubMed ID: 37164130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for Persistent Immune Suppression in Patients Who Develop Chronic Critical Illness After Sepsis.
    Stortz JA; Murphy TJ; Raymond SL; Mira JC; Ungaro R; Dirain ML; Nacionales DC; Loftus TJ; Wang Z; Ozrazgat-Baslanti T; Ghita GL; Brumback BA; Mohr AM; Bihorac A; Efron PA; Moldawer LL; Moore FA; Brakenridge SC
    Shock; 2018 Mar; 49(3):249-258. PubMed ID: 28885387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic Critical Illness and PICS Nutritional Strategies.
    Rosenthal MD; Vanzant EL; Moore FA
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34070395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluid strategies and outcomes in patients with acute respiratory distress syndrome, systemic inflammatory response syndrome and sepsis: a protocol for a systematic review and meta-analysis.
    Silversides JA; Ferguson AJ; McAuley DF; Blackwood B; Marshall JC; Fan E
    Syst Rev; 2015 Nov; 4():162. PubMed ID: 26563763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathophysiology of peritonitis].
    Beyer K; Menges P; Keßler W; Heidecke CD
    Chirurg; 2016 Jan; 87(1):5-12. PubMed ID: 26661744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic Critical Illness and Persistent Inflammation: What can we Learn from the Elderly, Injured, Septic, and Malnourished?
    Nomellini V; Kaplan LJ; Sims CA; Caldwell CC
    Shock; 2018 Jan; 49(1):4-14. PubMed ID: 28682945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.